CHMP recommends once-weekly Sogroya to treat growth hormone deficiency – Novo Nordisk
Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of once-weekly… read more.